# Clinical Trial Protocol: Randomized Placebo-Controlled Pilot Study of GcMAF (Soloways TM) in Patients With Metastatic Breast Cancer

> **NCT06434077** · PHASE3 · NOT_YET_RECRUITING · sponsor: **S.LAB (SOLOWAYS)** · enrollment: 60 (estimated)

## Conditions studied

- Breast Cancer

## Interventions

- **BIOLOGICAL:** GcMAF injections (100 ng)
- **OTHER:** placebo

## Key facts

- **NCT ID:** NCT06434077
- **Lead sponsor:** S.LAB (SOLOWAYS)
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-08-20
- **Primary completion:** 2026-09-20
- **Final completion:** 2026-12-20
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2025-06-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06434077

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06434077, "Clinical Trial Protocol: Randomized Placebo-Controlled Pilot Study of GcMAF (Soloways TM) in Patients With Metastatic Breast Cancer". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06434077. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*